Aprea Therapeutics, Inc. (APRE)
0.8052
+0.16
(+25.75%)
USD |
NASDAQ |
Aug 24, 16:00
0.75
-0.06
(-6.86%)
After-Hours: 20:00
Aprea Therapeutics Total Assets (Quarterly) : 42.29M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.29M |
| March 31, 2026 | 48.11M |
| December 31, 2025 | 15.93M |
| September 30, 2025 | 14.32M |
| June 30, 2025 | 17.31M |
| March 31, 2025 | 20.22M |
| December 31, 2024 | 23.98M |
| September 30, 2024 | 26.89M |
| June 30, 2024 | 29.96M |
| March 31, 2024 | 33.20M |
| December 31, 2023 | 22.65M |
| September 30, 2023 | 25.77M |
| June 30, 2023 | 28.68M |
| March 31, 2023 | 32.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 30.16M |
| September 30, 2022 | 33.62M |
| June 30, 2022 | 40.68M |
| March 31, 2022 | 50.34M |
| December 31, 2021 | 56.82M |
| September 30, 2021 | 62.48M |
| June 30, 2021 | 71.55M |
| March 31, 2021 | 80.39M |
| December 31, 2020 | 92.81M |
| September 30, 2020 | 102.83M |
| June 30, 2020 | 114.82M |
| March 31, 2020 | 125.13M |
| December 31, 2019 | 133.61M |
| September 30, 2019 | 57.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zymeworks, Inc. | 396.96M |
| Rhythm Pharmaceuticals, Inc. | 437.27M |
| Onconetix, Inc. | 16.43M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.092M |
| Shareholders Equity (Quarterly) | 39.20M |
| Current Ratio | 13.55 |